In recognition of the need for a more coordinated and multisectoral response to the growing cancer burden in kenya, the national assembly enacted the cancer prevention and control act (no. 15 of 2012) which established the National Cancer Institute of Kenya (NCI Kenya) as a state corporation. The overall mandate of the nci kenya is to coordinate all activities, resources and information related to cancer prevention and control in Kenya.
NCI-kenya recognizes that prioritizing and implementing cancer related interventions requires effective engagement and collaboration among all relevant stakeholders. Therefore, a stakeholder’s convention focused on cancer will take place from 2nd to 4th February 2023, culminating with the commemoration of world cancer day. This convention christened "The National Cancer Summit" is envisioned to bring together all stakeholders to discourse on identified areas of interest and to drive collective & impactful actions.
Register for the summit
The National Cancer Institute of Kenya is charged with the responsibility of coordinating cancer-related research to inform policy and practice. This is in line with the aspirations of the National Cancer Control Strategy for Kenya, 2017-2022 that highlighted research as a central strategy in all cancer control planning in the country. Although there has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace. The Institute is thus keen on cancer disparities and equity research and is therefore prioritizing the following research areas:
Basic science of pre-malignancy and prevention
Biomarkers, early detection, and screening
Cancer in minority populations and cancer health disparities
Risk factors: social determinants, environment/physical determinants, biological factors, behavioral factors, protective and/or Resiliency factors and Co-morbidities
Clinical epidemiology, lifestyle, and environmental risk factors
Molecular epidemiology, cancer genetics, and predisposition genes
Precision cancer prevention
Precision molecular diagnostics
Post-treatment surveillance, survivorship and energetics